alz-801
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Sep 16, 2015 (NCT04585347)
Timeline
Indications
Studied for
Mechanism of action
NAE1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06304883 | Phase 3 | Apr 2, 2024 | Alzheon Inc. |
| NCT04770220 | Phase 3 | May 19, 2021 | Alzheon Inc., National Institute on Aging (NIA) |
| NCT04693520 | Phase 2 | Sep 30, 2020 | Alzheon Inc. |
| NCT04157712 | Phase 1 | Sep 26, 2015 | Alzheon Inc., Quotient |
| NCT04585347 | Phase 1 | Sep 16, 2015 | Alzheon Inc., Quotient |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alzheon Inc. | For profit | 5 | 5 | 3 | 2015 |
| Quotient | For profit | 2 | 0 | 1 | 2015 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1